The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs ...

Shares of biotech Summit Therapeutics ( SMMT 9.31%) skyrocketed 583.7% in 2024, according to data from S&P Global Market ...

The Food and Drug Administration (FDA) has issued a “Dear Veterinarian Letter” regarding reports of adverse events in dogs ...

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by ...

The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...

Monoclonal Antibody to Inhibit IL33 for Autoimmune Disorders is under clinical development by Eli Lilly and Co and currently in Phase I for Autoimmune Disorders.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GSK5764227 (GSK’227) for the treatment of adult patients with relapsed or refractory (R/R) osteosarcoma who have ...

According to Inan’s team: “There is no documented production process of atezolizumab biosimilar in the literature except one ...

Tiziana Life Sciences (TLSA) announced findings on the prolonged benefits of its nasal anti-CD3 monoclonal antibody in sustaining tissue ...